SCOPUS 정보 검색 플랫폼

Volumn 345, Issue 20, 2001, Pages 1495-1497

Therapy for acute hepatitis C

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; INTERFERON; PEGINTERFERON ALPHA2A; RIBAVIRIN;

ANTIVIRAL ACTIVITY; DRUG INDUCED DISEASE; EDITORIAL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ACUTE DISEASE; ANTIVIRAL AGENTS; DISEASE PROGRESSION; HEPATITIS C; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2B;

EID: 0035892034 PISSN: 00284793 EISSN: None Source Type: Journal
DOI: 10.1056/NEJM200111153452013 Document Type: Editorial

Times cited : (41)

References (15)

1
- 0034651580
- Pathogenesis, natural history, treatment, and prevention of hepatitis C
- (2000) Ann Intern Med , vol.132 , pp. 296-305
- Liang, T.J.¹ Rehermann, B.² Seeff, L.B.³ Hoofnagle, J.H.⁴

2
- 0033584440
- The prevalence of hepatitis C virus infection in the United States, 1988 through 1994
- (1999) N Engl J Med , vol.341 , pp. 556-562
- Alter, M.J.¹ Kruszon-Moran, D.² Nainan, O.V.³

3
- 0031711489
- Hepatocellular carcinoma
- (1998) Hepatology , vol.28 , pp. 1161-1165
- Di Bisceglie, A.M.¹ Carithers R.L., Jr.² Gores, G.J.³

4
- 0033998786
- The past incidence of hepatitis C virus infection: Implications for the future burden of chronic liver disease in the United States
- (2000) Hepatology , vol.31 , pp. 777-782
- Armstrong, G.L.¹ Alter, M.J.² McQuillan, G.M.³ Margolis, H.S.⁴

5
- 0002727348
- Acute hepatitis C
- Liang TJ, Hoofnagle JH, eds. San Diego, Calif.: Academic Press
- (2000) Hepatitis C: biomedical research reports , pp. 71-83
- Hoofnagle, J.H.¹

6
- 0035892032
- Treatment of acute hepatitis C with interferon alfa-2b
- (2001) N Engl J Med , vol.345 , pp. 1452-1457
- Jaeckel, E.¹ Cornberg, M.² Wedemeyer, H.³

7
- 0030886964
- National Institutes of Health Consensus Development Conference Panel statement: Management of hepatitis C
- (1997) Hepatology , vol.26 , Issue.SUPPL. 1

8
- 0032547938
- Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
- (1998) N Engl J Med , vol.339 , pp. 1485-1492
- McHutchison, J.G.¹ Gordon, S.C.² Schiff, E.R.³

9
- 0034619946
- Peginterferon alfa-2a in patients with chronic hepatitis C
- (2000) N Engl J Med , vol.343 , pp. 1666-1672
- Zeuzem, S.¹ Feinman, S.V.² Rasenack, J.³

10
- 0035934568
- Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial
- (2001) Lancet , vol.358 , pp. 958-965
- Manns, M.P.¹ McHutchison, J.G.² Gordon, S.C.³

11
- 0000268538
- Pegylated (40 kDa) interferon alfa-2a (PEGASYS) in combination with ribavirin: Efficacy and safety results from a phase III, randomized, actively-controlled, multicenter study
- abstract
- (2001) Gastroenterology , vol.120 , Issue.SUPPL. 1
- Fried, M.W.¹ Shiffman, M.L.² Reddy, R.K.³

12
- 0032841846
- Pathogenesis of chronic hepatitis C: Immunological features of hepatic injury and viral persistence
- (1999) Hepatology , vol.30 , pp. 595-601
- Cerny, A.¹ Chisari, F.V.²

13
- 0034030136
- Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C
- (2000) Nat Med , vol.6 , pp. 578-582
- Takaki, A.¹ Wiese, M.² Maertens, G.³

14
- 0033576001
- Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening
- (1999) N Engl J Med , vol.341 , pp. 866-870
- Vogt, M.¹ Lang, T.² Frösner, G.³

15
- 0033594380
- Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin
- (1999) N Engl J Med , vol.340 , pp. 1228-1233
- Kenny-Walsh, E.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.